Physician profile
Brandon M Tauberg
NPI 1992117006
$53,582.84
in general payments reported to CMS, 2019-2025
19 companies · $1,896 in 2025
The $1,896 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $2,673 · 2021: $40K · 2022: $4,056 · 2023: $575 · 2024: $3,960 · 2025: $1,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,033 · Food and Beverage: $2,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,032.62 |
| Food and Beverage | $2,398.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $29,568.17 | 2021-2025 | |
| Medinc of Texas | $9,323.93 | 2020-2021 | |
| Mid-Atlantic Surgical Systems, LLC | $7,290.33 | 2021-2025 | |
| Smith+Nephew, INC. | $2,660.95 | 2020-2021 | |
| Medical Device Business Services, INC. | $2,571.29 | 2021 | |
| Stryker Corporation | $730.39 | 2019-2025 | Inspace |
| Depuy Synthes Sales INC. | $408.69 | 2019-2025 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $314.85 | 2022-2023 | Tapestry |
| Acell, INC. | $309.37 | 2019-2020 | |
| Miach Orthopaedics, INC. | $144.13 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $48.07 | 2021-2022 | |
| Innovation Technologies INC | $40.50 | 2023 | Irrisept |
| Wright Medical Technology, INC. | $40.47 | 2020 | |
| Linvatec Corporation | $33.92 | 2025 | Biobrace 23mm |
| Grt US Holding, INC. | $26.14 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $22.41 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.71 | 2021 | |
| Bioventus LLC | $17.02 | 2021 | |
| Amgen INC. | $13.50 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Tauberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.